You are using an unsupported browser. Please switch to a different browser to get the best experience.
Promotional information from Santen for healthcare professionals only. Prescribing information can be found below or to the right.

Adverse events should be reported. For UK: Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Santen UK Limited (email: medinfo@santen.co.uk or telephone: 0345 075 4863). For Ireland: Reporting forms and information can be found at www.hpra.ie. Adverse events should also be reported to Santen UK Limited (email: medinfo@santen.co.uk or telephone: +353 1 695 0008).

Our products

Explore our range of Santen products

Dry Eye Disease

Ikervis® (ciclosporin 1 mg/mL) is indicated for treatment of severe keratitis in adults with dry eye disease (DED), which has not improved despite treatment with tear substitutes.

Ikervis Prescribing information UK

Ikervis Prescribing information IE


Glaucoma Medicine

Catiolanze® emulsion is indicated for the reduction of elevated IOP in adult patients with OHT/OAG. 

Catiolanze emulsion is indicated for the reduction of elevated IOP in children from 4 years of age and adolescents with elevated IOP and paediatric glaucoma.

Catiolanze Prescribing information UK

Catiolanze Prescribing information IE

Roclanda is indicated for the reduction of IOP in adult patients with primary open-angle glaucoma or ocular hypertension for whom monotherapy with a prostaglandin or netarsudil provides insufficient IOP reduction.

Roclanda Prescribing information UK

Roclanda Prescribing information IE


Glaucoma Surgical

PRESERFLO MicroShunt Instructions for use can be downloaded below.
For UK: https://www.santen.uk/preserfloinstructionsforuse-UK
For Ireland: https://www.santen.ie/preserfloinstructionsforuse-IE


Vernal Keratoconjunctivitis (VKC)

Verkazia (ciclosporin 0.1%) is indicated for the treatment of severe vernal keratoconjunctivitis (VKC) in children from 4 years of age and adolescents.

Verkazia Prescribing information UK

Verkazia Prescribing information IE

This site is for
Healthcare Professionals ONLY